SCHEMBL7975119

SCHEMBL7975119

COc1ccccc1-c1nc2ncn(Cc3ccccc3)c2c(=O)[nH]1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
HPGD P15428 1/20 0.53
KMT2A Q03164 1/20 0.52
GAA P10253 1/20 0.49
FGFR1 P11362 2/20 0.47
FGFR2 P21802 2/20 0.47
CXCR2 P25025 1/20 0.47
PDE5A O76074 5/20 0.46
AURKA O14965 1/20 0.46
ACP1 P24666 1/20 0.46
PDE1A P54750 1/20 0.44
PDE1B Q01064 1/20 0.44
PDE1C Q14123 1/20 0.44
GUSB P08236 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988610 0.84 GUSB (0.54) ALDH1A1SMN1; SMN2HPGDKMT2AGAA
SCHEMBL7974850 0.84 SMN1; SMN2 (0.56) ALDH1A1SMN1; SMN2HPGDKMT2AGAA
SCHEMBL7985535 0.83 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2HPGDKMT2AGAA
SCHEMBL7974644 0.83 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2HPGDKMT2AGAA
SCHEMBL7975123 0.83 CXCR2 (0.50) GAACXCR2ACP1
SCHEMBL7985230 0.83 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2HPGDKMT2AGAA
SCHEMBL7985355 0.82 GAA (0.56) ALDH1A1SMN1; SMN2HPGDKMT2AGAA
SCHEMBL7975265 0.81 SMN1; SMN2 (0.61) ALDH1A1SMN1; SMN2HPGDKMT2AGAA
SCHEMBL7985702 0.80 HPGD (0.50) ALDH1A1SMN1; SMN2HPGDKMT2AGAA
SCHEMBL7974583 0.80 GAA (0.59) ALDH1A1SMN1; SMN2HPGDKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed